COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study
March 2024
in “
PubMed
”
Studysummary This study found a high prevalence of telogen effluvium among patients hospitalized for severe COVID-19, with most experiencing early onset and eventual complete hair regrowth.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on hrcak.srce.hr →